“The Inflation Reduction Act (IRA) will affect the cost of medicines in Medicare. Since making drugs less expensive is an objective of the law, I spoke with two experts in drug costs about it: AEI’s Amitabh Chandra and Craig Burton of the Association for Accessible Medicines. We concentrated on how the IRA will affect the availability and cost of generics and biosimilars, drug prices, and patient out-of-pocket costs more broadly.”